Save time and get answers to complex questions with AI chat
What's the advised delay for milk post lipitor?Dabrafenib btd date 2023?When oxcarbazepine patent expired?Combivent inhaler hfc 152a patents?Campath litigation germany?
See the DrugPatentWatch profile for humira
Humira (adalimumab) is a biologic medication that belongs to the class of tumor necrosis factor‑α (TNF‑α) inhibitors. It’s used to treat a range of inflammatory and autoimmune conditions by neutralizing TNF‑α, a protein that drives inflammation. Here are the main approved uses:
Humira is primarily used to treat inflammatory arthritis, inflammatory bowel disease, plaque psoriasis, and hidradenitis suppurativa, among other conditions. Its effectiveness comes from blocking TNF‑α, a key driver of inflammation. While it offers significant symptom relief and disease control, it requires careful monitoring for infections and other side effects. Always discuss your specific situation with a qualified healthcare provider before starting or changing therapy.
Other Questions About Humira :